Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan

Chest

Volumn 143, Issue 1, 2013, Pages 172-178

  Chang, Boksoon ^a   Hwang, Jung Hye ^a   Choi, Yoon Ho ^a   Chung, Man Pyo ^a   Kim, Hojoong ^a   Kwon, O Jung ^a   Lee, Ho Yun ^a   Lee, Kyung Soo ^a   Shim, Young Mog ^a   Han, Joungho ^a   Um, Sang Won ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GROUND GLASS OPACITY; HUMAN; LOW ENERGY RADIATION; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; TUMOR GROWTH; TUMOR VOLUME;

EID: 84871962254     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2501     Document Type: Article

References (27)

1. Aberle DR, Adams AM, Berg CD, et al National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409.
2. Austin JH, Müller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology. 1996;200(2):327-331. (Pubitemid 26249879)
3. Collins J, Stern EJ. Ground-glass opacity at CT: the ABCs. AJR Am J Roentgenol. 1997;169(2):355-367. (Pubitemid 27334842)
4. Lee HY, Lee KS. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications. J Thorac Imaging. 2011;26(2):106-118.
5. Henschke CI, Shaham D, Yankelevitz DF, et al. CT screening for lung cancer: significance of diagnoses in its baseline cycle. Clin Imaging. 2006;30(1):11-15. (Pubitemid 41828067)
6. Nakajima R, Yokose T, Kakinuma R, Nagai K, Nishiwaki Y, Ochiai A. Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assist Tomogr. 2002;26(3):323-329. (Pubitemid 34564205)
7. Nakata M, Saeki H, Takata I, et al. Focal ground-glass opacity detected by low-dose helical CT. Chest. 2002;121(5):1464-1467. (Pubitemid 34499656)
8. Kuriyama K, Seto M, Kasugai T, et al. Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung. AJR Am J Roentgenol. 1999;173(2):465-469. (Pubitemid 29347378)
9. Kushihashi T, Munechika H, Ri K, et al. Bronchioloalveolar adenoma of the lung: CT-pathologic correlation. Radiology. 1994;193(3):789-793. (Pubitemid 24366955)
10. Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS; ELCAP Group. CT screening for lung cancer: frequency and significance of part-solid and non-solid nodules. AJR Am J Roentgenol. 2002;178(5):1053-1057. (Pubitemid 34411393)
11. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol. 2000;73(876):1252-1259. (Pubitemid 32123826)
12. Fukui T, Mitsudomi T. Small peripheral lung adenocarcinoma: clinicopathological features and surgical treatment. Surg Today. 2010;40(3):191-198.
13. Godoy MC, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology. 2009;253(3):606-622.
14. Takamochi K, Nagai K, Yoshida J, et al. Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings. J Thorac Cardiovasc Surg. 2001;122(2):325-330.
15. Usuda K, Saito Y, Sagawa M, et al. Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer. 1994;74(8):2239-2244. (Pubitemid 24322277)
16. Schwartz M. A biomathematical approach to clinical tumor growth. Cancer. 1961;14 :1272-1294.
17. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244-285.
18. Hiramatsu M, Inagaki T, Inagaki T, et al. Pulmonary groundglass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth. J Thorac Oncol. 2008;3(11):1245-1250.
19. Kakinuma R, Ohmatsu H, Kaneko M, et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr. 2004;28(1):17-23. (Pubitemid 38057850)
20. Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg. 2002;73(2):386-392. (Pubitemid 34117375)
21. Lee HJ, Goo JM, Lee CH, Yoo CG, Kim YT, Im JG. Nodular ground-glass opacities on thin-section CT: size change during follow-up and pathological results. Korean J Radiol. 2007;8(1):22-31.
22. Aoki T, Nakata H, Watanabe H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol. 2000;174(3):763-768. (Pubitemid 30126259)
23. Takashima S, Maruyama Y, Hasegawa M, et al. CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. AJR Am J Roentgenol. 2003;180(3):817-826. (Pubitemid 36237235)
24. Saito H, Yamada K, Hamanaka N, et al. Initial findings and progression of lung adenocarcinoma on serial computed tomography scans. J Comput Assist Tomogr. 2009;33(1):42-48.
25. Park CM, Goo JM, Kim TJ, et al. Pulmonary nodular groundglass opacities in patients with extrapulmonary cancers: what is their clinical significance and how can we determine whether they are malignant or benign lesions? Chest. 2008;133(6):1402-1409. (Pubitemid 351892997)
26. Soda H, Nakamura Y, Nakatomi K, et al. Stepwise progression from ground-glass opacity towards invasive adenocarcinoma: long-term follow-up of radiological findings. Lung Cancer. 2008;60(2):298-301. (Pubitemid 351609137)
27. Min JH, Lee HY, Lee KS, et al. Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: an observation for more than 10 years. Lung Cancer. 2010;69(1):123-126.